RecruitingPhase 4NCT06993038

Adenosine vs Diltiazem for Treatment of SVT in the ED

COMparison of Adenosine Versus Diltiazem FOR Supraventricular Tachycardia in the ED (COMFORT-ED) - Pilot Trial

Sponsor

Anne E. Zepeski

Enrollment

20 participants

Start Date

Aug 1, 2025

Study Type

INTERVENTIONAL

Conditions

Supraventricular Tachycardia (SVT)

Summary

This is a small, pilot study with a primary goal of assessing patient perceptions of two medication treatments for supraventricular tachycardia in adult patients treated in the Emergency Department.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called adenosine and a drug called diltiazem for people with supraventricular tachycardia (svt). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGadenosine

IV adenosine at standard doses for SVT (6 mg, 12 mg)

DRUGdiltiazem

IV diltiazem at standard doses for SVT (0.25 mg/kg)

Locations(1)

University of Iowa Health Care

Iowa City, Iowa, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06993038

Related Trials

PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in the Emergency Department

NCT070865601 location